Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)

Autor: Holmsten, Karin, Jensen, Niels Viggo, Mouritsen, Lene Sonne, Jonsson, Erika, Mellnert, Camilla, Agerbæk, Mads, Nilsson, Cecilia, Moe, Mette, Carus, Andreas, Öfverholm, Elisabeth, Lahdenperä, Outi, Brandberg, Yvonne, Johansson, Hemming, Hellström, Mats, Maase, Hans von der, Pappot, Helle, Ullén, Anders
Zdroj: In European Journal of Cancer March 2020 127:173-182
Databáze: ScienceDirect
Externí odkaz: